Sign in to follow
Search Results

0 results for 'Sterne, Kessler, Goldstein & Fox'

You can use to get even better search results
June 21, 2010 |

Civil Actions

Tie-breaker? A move's afoot to bring retired Supreme Court justices back to the high court bench when a recusal could result in the dreaded 4-4 split. Also in this week's Inadmissible: Cobell extensions may run out of time; Dawn Johnsen's first public remarks since her failed nomination; a DOJ reunion of sorts; Chamber steps up fight against McConnell; judge seeks speedy justice on Wone trail; and a lobby shop Thais one on.
3 minute read
IP Boutiques: Reports of Their Death Greatly Exaggerated
Publication Date: 2008-08-05
Practice Area:
Industry:
Court:
Judge:
Attorneys:
For plaintiff:
For defendant:
Case number:

May 26, 2000 |

Genomic Warfare

Three shareholder class action suits have been filed so far against Celera Genomics Group, where scientists hope to soon complete the world's first map of the human genome. The suits claim Celera misrepresented the viability of its business plan, which, according to the first filed, "is dependent upon its ability to protect its database [of genomic] information through patent protection."
15 minute read
March 16, 2012 |

Full Federal Circuit issues pro-patent owner ruling on intervening rights

In a split en banc decision, the U.S. Court of Appeals for the Federal Circuit has reversed its own controversial September 2011 panel ruling about an alleged infringer's right to sell a product based on a patent claim changed in a patent office action. The decision came as good news to patent holders.
6 minute read
October 26, 2009 |

D.C. metro area's largest law offices

41 minute read
October 19, 2012 |

Associates Class of 2012

The Law Journal's annual new-associate magazine.
138 minute read
January 16, 2012 |

D.C. MOVES

4 minute read
June 15, 2009 |

D.C. Calendar of Events

4 minute read
February 10, 2012 |

A big win for generic drug makers at the Federal Circuit

A brand-name drug company can't sue generic drug companies for patent infringement if the generics ask the government to approve only nonpatented uses for the drug, the U.S. Court of Appeals for the Federal Circuit has ruled.
4 minute read
June 22, 2009 |

D.C. Calendar of Events

3 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources